Relpax and Vesicare drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Vesicare (solifenacin succinate). Common drug interactions include weight decreased among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Vesicare. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

On Jul, 17, 2026

54 people who take Relpax and Vesicare together, and have interactions are studied.

What are the common drug interactions of Relpax and Vesicare, by gender? *:

female:

Weight decreased
Pneumonia
Memory impairment
Fall
Headache (pain in head)
Disturbance in attention
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cerebrovascular disorder (disease of brain)
Confusional state

male:

Death
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Weight decreased
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Drug hypersensitivity
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Intestinal perforation (complete penetration of the wall of the intestine)
Pneumonia
Post procedural fistula

What are the common drug interactions of Relpax and Vesicare, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Lower respiratory tract infection

30-39:

Chronic kidney disease
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Headache (pain in head)
Maternal exposure during pregnancy (use of substance during pregnancy)
Abortion spontaneous (naturally occurring miscarriage)
Drug exposure during pregnancy
Pregnancy
Blighted ovum

40-49:

Sepsis (a severe blood infection that can lead to organ failure and death)
Pneumonia
Weight decreased
Drug hypersensitivity
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Intestinal perforation (complete penetration of the wall of the intestine)
Post procedural fistula
Postoperative wound infection
Coma (state of unconsciousness lasting more than six hours)

50-59:

Memory impairment
Fall
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cerebrovascular disorder (disease of brain)
Confusional state
Depressed mood
Diplopia (double vision)
Disturbance in attention
Gammopathy (abnormal proliferation of the lymphoid cells producing immunoglobulins)

60+:

Anxiety
Depression
Dysgraphia (impaired ability to learn to write)
Feeling cold
Headache (pain in head)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Influenza like illness
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site haemorrhage (bleeding from injection site)
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Depression: 19 people, 35.19%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 15 people, 27.78%
Insomnia (sleeplessness): 13 people, 24.07%
Pain: 13 people, 24.07%
High Blood Pressure: 10 people, 18.52%
Bladder Disorder: 9 people, 16.67%
Neuropathy Peripheral (surface nerve damage): 8 people, 14.81%
Muscle Spasms (muscle contraction): 8 people, 14.81%
Fatigue (feeling of tiredness): 8 people, 14.81%
Headache (pain in head): 7 people, 12.96%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Vesicare?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously